PositiveID
ExcitePCR's technology detects pathogens in 30 minutes or less using a backpack-sized device, integrating sample prep with PCR and RIF technology in a disposable cartridge.
PositiveID Forms Subsidiary to Develop PCR-Based Pathogen Detection System
The subsidiary, called ExcitePCR, will own and complete development of the company's Firefly Dx real-time PCR breadboard prototype pathogen detection system.
In Brief This Week: Qiagen; DiaSorin; Quest; Agilent; Thermo Fisher Scientific; and More
Qiagen has extended the offer period for its DKK683 million ($103.5 million) acquisition of Exiqon.
PositiveID 2015 Revenues Balloon on License Fee, Recent Acquisitions
The company's revenues were primarily derived from a deferred license fee from Boeing, with the remainder coming from the operations of two recent acquisitions.
PositiveID Inks Deal for $2.4M in Financing
Proceeds will go toward the further development and field testing of the Firefly DX system and for general working capital.
Nov 26, 2014
PositiveID to Issue $4M in Senior Notes to Investor
May 2, 2013
Dec 8, 2011
Jul 20, 2011